# GelrinC

Type: Product

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/gelrinc
Canonical HTML page: https://gethealthbrief.com/entity/gelrinc

## Recent coverage (1 stories)

### Regentis Biomaterials Scales GelrinC Production with 400% Yield Increase
2026-03-17 15:24:59 · Sentiment: Strongly positive · Impact: 7/10 · Sources: 2

Regentis Biomaterials has patented a breakthrough solvent-free manufacturing process for its GelrinC hydrogel, achieving a 400% increase in production yield. This advancement positions the company for large-scale commercialization while improving the environmental profile and cost-efficiency of its cartilage repair solution.
Full story: https://gethealthbrief.com/story/regentis-biomaterials-gelrinc-manufacturing-breakthrough

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.